Skip to main content
. 2022 Jul 30;14(8):1590. doi: 10.3390/pharmaceutics14081590

Figure 2.

Figure 2

Targeting the folate, purine, and hypusine biosynthesis pathways in Leishmania through a drug repurposing approach.